Stocks To Buy Forum

Stocks to Buy based on the Best Stock Market Research

Stocks to Buy 6/15/17 June 15, 2017 - @stockstobuy - Twitter

Below is a list of stocks to watch on Thursday.  These stocks are active and have the potential to break out this week.

Check out my Stock Picks for 2017 - Stocks to Buy 2018 - Best Penny Stocks 2017

Intrexon (XON) - Intrexon (XON) dropped into the $21's recently which caused me to start a position.  XON has been mentioned as the stock of the decade by early AMZN investor Bill Miller.  XON is a strong buy below $20 and that is what I plan to do.

Apple (AAPL) - Apple (AAPL) is now seeing a large correction as predicted. AAPL remains a strong sell right now.

IBM (IBM) - IBM is forming a base around $150 and is looking good for the long term right now.  This is a cheapest value tech stock for the money right now.

Tesla (TSLA) - Tesla (TSLA) tanked this week but is now on fire again.   Tesla (TSLA) is a strong buy below $250 if we ever see another major correction.

Small Cap Bull 3x (TNA) - TNA is racing back up near a 52 week high.  TNA is a strong buy below $43 over the next three months.

Shake Shack (SHAK) - Shake Shack (SHAK) has rallied 30% since earnings and is trading near the recent high.  The company reported strong earnings and sandbagged Q2 guidance last quarter.  Expect a big beat in two months.

Chipotle (CMG) - Chipotle (CMG) hit a 52 week high recently but is now pulling back.  CMG is now a buy on all major pullbacks and should see $510-$560 over the next 3-6 months.

China 3x Bull ETF (YINN) - YINN is pulling back with the stock market after a large run.  YINN is a strong buy below $17 if we ever see another big drop.  Resistance will be located up around $23.

Check out my Stock Picks for 2017 - Stocks to Buy 2018 - Best Penny Stocks 2017 Oil Stocks 2017

Stocks to Watch - 6/15/17

Liniu Tech (LINU)
Ekso Bionics (EKSO)
Medical Transcription (MTBC)
Monster Digital (MSDI)
Lee Enterprises (LEE)
Mabvax Therapeutics (MBVX)

China CR (CCCR)
Redhill Biopharma (RDHL)

Views: 439

Comment

You need to be a member of Stocks To Buy Forum to add comments!

Join Stocks To Buy Forum

Comment by Stocks To Buy on June 15, 2017 at 9:37am

Today's Biggest Gainers - SKLN HTGM EKSO IDXG ROX LAKE APPS AVID UVXY

Comment by Stocks To Buy on June 15, 2017 at 9:36am

I plan to sell HTGM above $5.10 for a profit or double my position around $2.  Nothing will change

Comment by Brian on June 15, 2017 at 9:23am
What does this mean for HTGM now? Will you try to double your position at a higher price than 2 or just try to sell above your original buy in?
Comment by Stocks To Buy on June 15, 2017 at 7:49am
Comment by Stocks To Buy on June 15, 2017 at 6:45am

The Dow Jones Futures are lower by 90 points in pre market this morning.  AAPL continues to break down as shares were a strong sell over the last few months.  HTGM received some positive news and hit $4.40 last night where it struggled.  HTGM will continue to face heavy resistance between $4.25-$4.40.  XON is up 18% from the low two weeks ago but will face heavy resistance between $24-$25.

Comment by Stocks To Buy on June 14, 2017 at 5:47pm

HTGM up 30% tonight

        HTG Molecular Diagnostics, Inc. (the "Company") entered into a statement of work (the "SOW") with QIAGEN Manchester Limited ("QIAGEN"), a U.K. corporation and wholly owned subsidiary of QIAGEN N.V. The SOW was entered into pursuant to the Company's Master Assay Development, Commercialization and Manufacturing Agreement (the "Master Agreement") with QIAGEN, and addresses development activities expected to be conducted by the Company and QIAGEN in connection with the initial phase of a sponsor project agreement entered into between QIAGEN and a pharmaceutical company ("Initial Phase").

Under the SOW, the Company and QIAGEN are expected to perform development work for the Initial Phase of what is expected to become a multi-stage project leading to the potential development and commercialization of a next generation sequencing-based companion diagnostic assay. The development work is expected to support one of the pharmaceutical company's therapeutic development and commercialization programs. QIAGEN will pay the Company low single digit millions of dollars for the Initial Phase development work performed under the SOW, and the Company and QIAGEN will also share in any net profits (as determined under the Master Agreement) generated by the Initial Phase.

In connection with the execution of the SOW, HTG and QIAGEN also amended the Master Agreement, to provide that, in the event of a change in control, neither party will be able to terminate the SOW, or the Master Agreement to the extent it relates to the SOW.

QIAGEN North American Holdings, Inc., a wholly-owned subsidiary of QIAGEN N.V., owns 833,333 shares of our common stock.     

Stocks to Buy 2018

Stocks to Buy 2018

Tesla (TSLA)
Small Cap Bull 3x (TNA)
Shake Shack (SHAK)
Stocks to Watch - 2018
Penny Stocks - 2018



Twitter - Free Stock Alerts

© 2017   Created by Stocks To Buy.   Powered by

Badges  |  Report an Issue  |  Terms of Service